CD8A and neoplasm: We examined the therapeutic efficacy of the combination of AIMS(EPT, R848, PTX) and ICB in two different tumor models (4T1 and TC1 tumor cells) and observed that tumor volume and weight were decreased significantly and CD8+ T cells were highly increased in the combination group compared with the ICBT alone group.